drugset / Trial / NCT05992896

A Study of Loco-Regional Liposomal Bupivacaine Injection

NCT05992896 ↗

Phase 4 Terminated 3 enrolled Mayo Clinic
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this research is to find out if using liposomal bupivacaine solution (bupivacaine liposome) injections during lower extremity revascularization surgery will lower the amount of narcotic drugs used during and following the procedure.

Timeline

Start
2023-09-26
Primary completion
2025-05-15
Completion
2025-06-30

Outcome

Outcome not reported

Stopped (Business): “Lack of funds”

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified — Other